SR

Shankar Rajaram Sontakke

Active Director Director DIN 07442788
DIN 07442788 First appointment Mar 2016 Primary industry Home Appliances
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Shankar Rajaram Sontakke

Data last updated:

Shankar Rajaram Sontakke is a Director at Daysaway Biolabs Private Limited (since 2016). The company operates in Home Appliances.

DIN 07442788
Primary Designation Director
Industry Home Appliances
First Appointment 11 Mar 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Daysaway Biolabs Private Limited U52334MH2016PTC274227
Director11 Mar 20162016Active

Board colleagues of Shankar Rajaram Sontakke

NameDINCompanyDesignation
Jyoti Gulabrao Jumde07468240Daysaway Biolabs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Daysaway Biolabs Private Limited
Premium access

Shareholding and investment profile for Shankar Rajaram Sontakke

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shankar Rajaram Sontakke

Shankar Rajaram Sontakke currently holds 1 directorship: Daysaway Biolabs Private Limited (Director, since 11 Mar 2016).

Shankar Rajaram Sontakke was first appointed on 11 Mar 2016 as Director at Daysaway Biolabs Private Limited.

The current boards of Shankar Rajaram Sontakke's companies include Jyoti Gulabrao Jumde (Daysaway Biolabs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available